Bavarian Nordic’s Vaccine Shows Biodefense Potential in Phase I
With a successful phase I clinical trial, Danish biotech Bavarian Nordic has come a step…
With a successful phase I clinical trial, Danish biotech Bavarian Nordic has come a step…
Update (20/12/2019): After getting conditional approval in Europe in November, Merck has received FDA approval…
Bavarian Nordic and AstraZeneca collaborate on a treatment that uses a cancer vaccine along with…
Tropical diseases are often neglected until an outbreak causes worldwide panic. Here’s how European biotech…
Bavarian Nordic has announced positive Phase II results for its universal vaccine against the common…
Just after a major clinical failure, BMS is now shipping Opdivo to Bavarian Nordic for…
Bavarian Nordic will receive €90M from the US' BARDA for its nonreplicating smallpox vaccine - which…
With its canals, the Little Mermaid and the oldest amusement park in the world, Copenhagen…
The hedge fund Kerrisdale Capital just published a report explaining its position in Bavarian Nordic,…
It's a really good news in the fight against Ebola. A vaccine has shown 100% success…
Bavarian Nordic has been granted €50M loan from the European Investment Bank (EIB) to support…
Bristol-Myers Squibb signs an exclusive agreement with Bavarian Nordic for PROSTVAC, a prostate-specific antigen-targeting cancer…